10314 Federal Register / Vol. 75, No. 43 / Friday, March 5, 2010 / Notices 

that the company’s registration is 

consistent with the public interest. The 

investigation has included inspection 

and testing of the company’s physical 

security systems, verification of the 

company’s compliance with state and 

local laws, and a review of the 

company’s background and history. 

Therefore, pursuant to 21 U.S.C. 823, 

and in accordance with 21 CFR 1301.33, 

the above named company is granted 

registration as a bulk manufacturer of 

the basic classes of controlled 

substances listed. 

Dated: February 26, 2010. 

Joseph T. Rannazzisi, 

Deputy Assistant Administrator, Office of 

Diversion Control, Drug Enforcement 

Administration. 

[FR Doc. 2010–4728 Filed 3–4–10; 8:45 am] 

BILLING CODE 4410–09–P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

Manufacturer of Controlled 

Substances; Notice of Registration 

By Notice dated October 20, 2009, and 

published in the Federal Register on 

October 28, 2009, (74 FR 55588), 

Aldrich Chemical Company, Inc., DBA 

Isotec, 3858 Benner Road, Miamisburg, 

Ohio 45342–4304, made application by 

renewal to the Drug Enforcement 

Administration (DEA) to be registered as 

a bulk manufacturer of the basic classes 

of controlled substances listed in 

schedules I and II: 

Drug Schedule 

Gamma Hydroxybutyric Acid 

(2010).

I 

Methaqualone (2565) ................... I 

Ibogaine (7260) ............................ I 

Tetrahydrocannabinols (7370) ..... I 

2,5-Dimethoxyamphetamine 

(7396).

I 

Psilocyn (7438) ............................. I 

Normorphine (9313) ..................... I 

Acetylmethadol (9601) ................. I 

Alphacetylmethadol except levo– 

alphacetylmethadol (9603).

I 

Normethadone (9635) .................. I 

Norpipanone (9636) ..................... I 

3-Methylfentanyl (9813) ................ I 

Amphetamine (1100) .................... II 

Methamphetamine (1105) ............ II 

Methylphenidate (1724) ................ II 

Amobarbital (2125) ....................... II 

Pentobarbital (2270) ..................... II 

Secobarbital (2315) ...................... II 

1-Phenylcyclohexylamine (7460) II 

Phencyclidine (7471) .................... II 

Phenylacetone (8501) .................. II 

1- 

Piperidinocyclohexanecarbonitrile (8603).

II 

Cocaine (9041) ............................. II 

Drug Schedule 

Codeine (9050) ............................. II 

Oxycodone (9143) ........................ II 

Hydromorphone (9150) ................ II 

Benzoylecgonine (9180) ............... II 

Ethylmorphine (9190) ................... II 

Hydrocodone (9193) ..................... II 

Isomethadone (9226) ................... II 

Meperidine (9230) ........................ II 

Meperidine intermediate-A (9232) II 

Meperidine intermediate-B (9233) II 

Methadone (9250) ........................ II 

Methadone intermediate (9254) ... II 

Dextropropoxyphene, bulk, (nondosage forms) (9273).II 

Morphine (9300) ........................... II 

Thebaine (9333) ........................... II 

Levo-alphacetylmethadol (9648) .. II 

Oxymorphone (9652) ................... II 

The company plans to manufacture 

small quantities of the listed controlled 

substances to produce isotope labeled 

standards for drug testing and analysis. 

No comments or objections have been 

received. DEA has considered the 

factors in 21 U.S.C. 823(a) and 

determined that the registration of 

Aldrich Chemical Company Inc., to 

manufacture the listed basic classes of 

controlled substances is consistent with 

the public interest at this time. DEA has 

investigated Aldrich Chemical Company 

Inc., to ensure that the company’s 

registration is consistent with the public 

interest. The investigation has included 

inspection and testing of the company’s 

physical security systems, verification 

of the company’s compliance with state 

and local laws, and a review of the 

company’s background and history. 

Therefore, pursuant to 21 U.S.C. 823, 

and in accordance with 21 CFR 1301.33, 

the above named company is granted 

registration as a bulk manufacturer of 

the basic classes of controlled 

substances listed. 

Dated: February 26, 2010. 

Joseph T. Rannazzisi, 

Deputy Assistant Administrator, Office of 

Diversion Control, Drug Enforcement 

Administration. 

[FR Doc. 2010–4723 Filed 3–4–10; 8:45 am] 

BILLING CODE 4410–09–P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

Manufacturer of Controlled 

Substances; Notice of Registration 

By Notice dated October 16, 2009, and 

published in the Federal Register on 

October 28, 2009, (74 FR 55586), Lin 

Zhi International Inc., 687 North 

Pastoria Avenue, Sunnyvale, California 

94085, made application by renewal to 

the Drug Enforcement Administration 

(DEA) to be registered as a bulk 

manufacturer of the basic classes of 

controlled substances listed in 

schedules I and II: 

Drug Schedule 

Tetrahydrocannabinols (7370) ..... I 

3,4- 

Methylenedioxymethamphetamine (MDMA) (7405).

I 

Cocaine (9041) ............................. II 

Oxycodone (9143) ........................ II 

Hydrocodone (9193) ..................... II 

Methadone (9250) ........................ II 

Dextropropoxyphene, bulk (nondosage forms) (9273).II 

Morphine (9300) ........................... II 

The company plans to manufacture 

the listed controlled substances as bulk 

reagents for use in drug abuse testing. 

No comments or objections have been 

received. DEA has considered the 

factors in 21 USC 823(a) and determined 

that the registration of Lin Zhi 

International Inc., to manufacture the 

listed basic classes of controlled 

substances is consistent with the public 

interest at this time. DEA has 

investigated Lin Zhi International Inc., 

to ensure that the company’s 

registration is consistent with the public 

interest. The investigation has included 

inspection and testing of the company’s 

physical security systems, verification 

of the company’s compliance with state 

and local laws, and a review of the 

company’s background and history. 

Therefore, pursuant to 21 USC 823, and 

in accordance with 21 CFR 1301.33, the 

above named company is granted 

registration as a bulk manufacturer of 

the basic classes of controlled 

substances listed. 

Dated: February 26, 2010. 

Joseph T. Rannazzisi, 

Deputy Assistant Administrator, Office of 

Diversion Control, Drug Enforcement 

Administration. 

[FR Doc. 2010–4719 Filed 3–4–10; 8:45 am] 

BILLING CODE 4410–09–P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

Manufacturer of Controlled 

Substances; Notice of Registration 

By Notice dated September 17, 2009, 

and published in the Federal Register 

on September 25, 2009, (74 FR 49020), 

Cerilliant Corporation, 811 Paloma 

Drive, Suite A, Round Rock, Texas 

78665–2402, made application by 

renewal to the Drug Enforcement 

Administration (DEA) to be registered as 

a bulk manufacturer of the basic classes 


erowe on DSK5CLS3C1PROD with NOTICES